Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07860580

Alpha-Tectorin, Interleukin-10 and Thiol-Disulfide Homeostasis in Children With Congenital Hearing Loss

Sponsor: Harran University

View on ClinicalTrials.gov

Summary

Congenital hearing loss is one of the most common sensory disorders of childhood, and the structural, immunologic and oxidative mechanisms involved in its development are incompletely understood. This case-control study aims to evaluate serum alpha-tectorin and interleukin-10 (IL-10) levels and thiol-disulfide homeostasis in children with congenital sensorineural hearing loss (cochlear implant users and hearing aid users) compared with healthy children with normal hearing. The findings are expected to contribute to a better understanding of the mechanisms underlying congenital hearing loss and to the identification of potential diagnostic and prognostic biomarkers.

Official title: Evaluation of Alpha-Tectorin, Interleukin-10, and Thiol-Disulfide Homeostasis in Individuals With Congenital Hearing Loss

Key Details

Gender

All

Age Range

Any - 17 Years

Study Type

OBSERVATIONAL

Enrollment

120

Start Date

2026-04-20

Completion Date

2027-04

Last Updated

2026-10-06

Healthy Volunteers

Yes

Interventions

OTHER

Blood sample collection

Collection of approximately 5 mL of venous blood for measurement of serum alpha-tectorin, interleukin-10 and thiol-disulfide homeostasis parameters; no additional intervention is applied.

Locations (1)

Harran University Faculty of Medicine Hospital, Department of Otorhinolaryngology

Sanliurfa, Turkey (Türkiye)